News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nutrien Ltd (NTR) stock rose 3.1% to $69.46, but GuruFocus's GF Value assesses it as 27.2% overvalued with a GF Score of 68/100. Despite a P/E ratio below its historical median, the overall valuation suggests caution for new investors due to limited growth potential …
Sharemaestro market context Price below Trend Line 52 weeks +21.3%Nutrien Ltd. generated a total revenue of 22.01 billion EUR last year. Its Retail segment was the top performer, contributing 15.25 billion EUR, although this was a decrease from the prior year's 16.40 billion EUR. The United States remained the largest regional contributor, accounting …
This article provides a comprehensive stock analysis of Nutex Health Inc (NUTX) through TradingKey's Stock Score system. It highlights the company's strong fundamentals and high growth potential, despite a weak short-term market performance. The analysis covers financial health, valuation, earnings forecasts, price momentum, institutional …
BNP Paribas has upgraded Nutrien (NTR) from Neutral to Outperform and increased its price target from CA$99.26 to CA$112.99. This upgrade reflects a more positive outlook on the agricultural chemicals company. The article also lists recent analyst actions on Nutrien, including other upgrades and …
This article provides a detailed company profile for Nutrien Ltd (NTR), a global provider of crop inputs and services. It covers the company's business scope, financial data including market cap and P/E ratio, and lists key executives and shareholders. The report also highlights that …
Barclays has reduced its target price for Nutrien Ltd (NTR.N) from $85 to $81. This news was reported by Reuters on July 27, 2026. The article explicitly states that its content reflects only the author's opinion and should not be used for investment decisions.
Barclays has reduced its target price for Nutrien Ltd (NTR.N) from $85 to $81. This news was reported by Reuters on July 27, 2026. The article explicitly states that its content reflects only the author's opinion and should not be used for investment decisions.
Sharemaestro market context Price below Trend Line 52 weeks +21.3%This article provides a detailed cash flow statement for Nutex Health Inc (NUTX), presenting both annual and quarterly data. It breaks down cash flows into operating, investing, and financing activities, along with key metrics like capital expenditures and free cash flow. The data aims …
Barclays has maintained an Overweight rating on Nutrien Ltd (NTR) but lowered its price target from $85.00 to $81.00, reflecting a cautious outlook amidst fluctuating market conditions, even though the company is currently trading 24.3% above its GF Value™ of $54.77. Nutrien's GF Score™ …
This article provides a detailed revenue breakdown for Nutriband Inc (NTRB), categorizing its revenue by business segments (Sale of goods, Services) and geographical regions (United States, Non-United States). As of the latest update, Nutriband Inc's revenue primarily comes from the sale of goods within …
This article provides a detailed quarterly and annual balance sheet for Nutriband Inc (NTRB), allowing investors to analyze the company's financial health, liquidity, leverage, and return on equity. It presents extensive financial data for various balance sheet items from FY2018Q1 to FY2027Q1. The content …
The article provides a detailed timeline of dividend distributions and stock splits for Nutex Health Inc (NUTX). It highlights that the company has not distributed any dividends in the past five years. However, it lists several merger-related stock splits with various ratios, predominantly occurring …
Nutex Health Inc. (MUN:5LF) reported a total revenue of 745.21 million EUR last year, with the Hospital segment being the top performer, contributing 718.74 million EUR. The company's revenue primarily came from the United States, which accounted for the entire 745.21 million EUR. This …
This article provides an analysis of Nutriband Inc (NTRB) focusing on its institutional confidence score and shareholder activity. It details the shares held by various individuals and entities, along with the percentage change in their holdings. The report presents the institutional confidence score, which …
Renaissance Technologies LLC reduced its stake in Herbalife Ltd (NYSE:HLF) by 2.1% in the first quarter, selling 119,600 shares, but still owned 5.31% of the company valued at $80.96 million. Despite this, several other institutional investors increased their holdings, including Manatuck Hill Partners LLC …
This article details the shareholder structure of Herbalife Ltd (HLF), listing its major shareholders such as The Baupost Group and BlackRock, along with their respective proportions. It also breaks down shareholder types, showing the dominance of investment advisors and hedge funds. Furthermore, the article …
This article provides a detailed revenue breakdown for Nutex Health Inc (NUTX) across its various business segments for FY2023Q1. The primary revenue sources include net patient service revenue, capitation revenue, management fees, and SaaS revenue. The data, updated as of March 4, 2025, shows …
Herbalife Ltd. generated 4.29 billion EUR in revenue last year, with its Weight Management segment being the top performer, contributing 2.34 billion EUR. Geographically, EMEA was the largest contributor to the company's revenue, accounting for 948.82 million EUR. The article provides a breakdown of …
This article provides an overview of Herbalife's market sentiment, including analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" consensus from analysts with an average price target of $15, despite some bearish signals from options flow and short interest. The …
Nutanix, Inc. Class A (MUN:0NU) generated a total revenue of €2.22 billion last year, with its Subscription segment being the primary contributor at €2.11 billion. The United States was the largest regional revenue source, accounting for €1.23 billion of the company's total revenue.
The global controlled-release fertilizers (CRF) market is projected to grow from USD 2.69 billion in 2026 to USD 3.61 billion by 2031, at a CAGR of 6.1%. This growth is driven by increasing demand for higher crop yields, improved nutrient use efficiency, and environmental …
Herbalife Ltd (HLF) reported its Q4 2023 earnings, missing EPS expectations with an actual EPS of $0.28 against a consensus of $0.40, a miss of -$0.12. However, the company beat revenue estimates, recording $1.22 billion against an expected $1.19 billion, reflecting a 2.90% YoY …
This article provides a detailed financial overview of Herbalife Ltd (HLF), including its stock performance, market capitalization, P/E ratio, and upcoming earnings date. It presents comprehensive financial statements like the Income Statement, Balance Sheet, and Cash Flow Statement, allowing investors to analyze the company's …
Nutriband Inc. (NTRB) is trading at $2.980, up 1.71%, with its fundamentals rated as very healthy and high growth potential. The company's valuation is considered fairly valued within the Healthcare Equipment & Supplies industry. Institutional ownership is high, and analysts have rated it as …
Nutriband Inc. (NASDAQ: NTRB) generated its primary revenue from the United States, contributing $2.03 million last year, a slight decrease from $2.14 million the previous year. The article provides a breakdown of the company's revenue by source and country.
Nutanix Inc (NTNX) is a cloud software company providing a single platform for hybrid multicloud infrastructure. The company's stock is currently trading at $66.615, down 1.96% for the day. Analysts rate Nutanix as a "Buy" with a target price of $59.064, and the company …
Nutrien Ltd. reported total revenue of 466.13 billion MXN last year, with its Retail segment being the top performer, generating 322.86 billion MXN. The United States was the largest geographical contributor, accounting for 299.47 billion MXN of the company's revenue. This financial data provides …
Sharemaestro market context Price below Trend Line 52 weeks +20.1% · Next-week setup negative 19.6%Nutrien's investor presentation highlights its strong strategic execution and operational performance, achieving record potash sales and higher Retail adjusted EBITDA through cost reduction and proprietary margin improvements. The company maintains a leading global agricultural solutions footprint with strong market positions in ag retail, potash, …
Oppenheimer has lowered its price target for Nutrien Ltd. (NTR) to $80 from $82, while reiterating an Outperform rating on the stock. This adjustment comes amidst other recent analyst activities, including a Buy rating from RBC and downgrades from Jefferies and Berenberg. Nutrien, a …
Faruqi & Faruqi, LLP is investigating potential claims against Nutanix, Inc. (NASDAQ: NTNX) and encourages investors who lost over $100,000 to contact them before the June 13, 2023 lead plaintiff deadline. The investigation follows disclosures that Nutanix allegedly misused third-party evaluation software for business …
Search by ticker symbol or company name and select a result to open its chart.